Run a Transparent Government

whitePaper | January 27, 2020

On September 27, 1998, football fans who tuned in to watch the game between the Baltimore Ravens and the Cincinnati Bengals witnessed much more than a 31-24 Bengal win. That Sunday, ESPN introduced a technological inno-vation that would forever change the way fans watch sports: a thin yellow line overlaid onto live video representing the distance required for a first down.

whitePaper | November 3, 2021

The Department of Defense (DoD) annual report to Congress on military and security developments involving the People’s Republic of China (PRC) provides a baseline assessment of the Department’s pacing challenge. The PRC has long viewed the United States as a competitor and has characterized its view of strategic competition in terms of a rivalry among powerful nation states, as well as a clash of opposing systems. As expressed in the Interim National Security Strategic Guidance, the PRC is the only competitor capable of combining its economic, diplomatic, military, and technological power to mount a sustained challenge to a stable and open international system. The PRC is increasingly clear in its ambitions and intentions.

whitePaper | December 10, 2019

The Trump administration, members of Congress from both parties, and many states have introduced proposals to combat high drug prices. Too often missing from these reform efforts, however, is a clear understanding of a root cause of the crisis: the suppression of fair market competition through various forms of monopoly. This white paper examines and proposes solutions for the two main ways that monopoly drives up the costs and lowers the quality of prescription drugs: increasing corporate concentration in the pharmaceutical industry, and the monopoly markets for individual drugs created by a deeply flawed and increasingly abused patent and regulatory system.

whitePaper | February 12, 2020

Both the U.S. Government and biopharmaceutical industry have been central engines for developing new medical treatments and cures, thereby lowering the effective price of better health for patients worldwide. The sector has done so by being both the world leader in these biopharmaceutical cures and treatments as well as the source of the returns that are required to fund new medical R&D investments.

whitePaper | May 27, 2022

Public policy-making processes are by their nature cumbersome, and not just because of the issues to be addressed. They also have to be inclusive and a myriad of competinginterests need to be addressed and to an extent satisfied.

whitePaper | May 25, 2022

On 22 July 1994, then 29-year-old army lieutenant Yahya Abdul-Aziz Jemus Junkung Jammeh came to power through a military coup d’état – having ousted the democratically elected President Sir Dawda Kairaba Jawara. For 22 years, Yahya Jammeh ruled The Gambia with an iron fist. During his regime, extrajudicial killings, rape, torture, enforced disappearances, and numerous grievous human rights violations became part and parcel of his military Junta.